Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons.
Neuronal nicotinic acetylcholine receptors (nAChRs) containing the α5 subunit modulate nicotine consumption, and the human CHRNA5 rs16969968 polymorphism, causing the replacement of the aspartic acid residue at position 398 with an asparagine (α5DN), has recently been associated with increased use of tobacco and higher incidence of lung cancer. We show that in ventral midbrain neurons, the α5 subunit is essential for heteromeric nAChR-induced intracellular-free Ca(2+) concentration elevations and that in α5(-/-) mice, a class of large-amplitude nicotine-evoked currents is lost. Furthermore, the expression of the α5DN subunit is not able to restore nicotinic responses, indicating a loss of function by this subunit in native neurons. To understand how α5DN impairs heteromeric nAChR functions, we coexpressed α4, α5, or α5DN subunits with a dimeric concatemer (β2α4) in a heterologous system, to obtain nAChRs with fixed stoichiometry. Both α5(β2α4)2 and α5DN(β2α4)2 nAChRs yielded similar levels of functional expression and Ca(2+) permeability, measured as fractional Ca(2+) currents (8.2 ± 0.7% and 8.0 ± 1.9%, respectively), 2-fold higher than α4(β2α4)2. Our results indicate that the loss of function of nicotinic responses observed in α5DN-expressing ventral midbrain neurons is neither due to an intrinsic inability of this subunit to form functional nAChRs nor to an altered Ca(2+) permeability but likely to intracellular modulation.
*Istituto Di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli, Italy; Department of Biology and Biotechnology "Charles Darwin," and Department of Physiology and Pharmacology, Institute Pasteur-Cenci Bolognetti Foundation, Sapienza University, Rome, Italy; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, United Kingdom; Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA; and Neurobiologie Intégrative des Systèmes Cholinergiques, and Centre National de la Recherche Scientifique Unités Mixtes de Recherche, Institut Pasteur, Paris, France.
Miriam
M
Sciaccaluga
*Istituto Di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli, Italy; Department of Biology and Biotechnology "Charles Darwin," and Department of Physiology and Pharmacology, Institute Pasteur-Cenci Bolognetti Foundation, Sapienza University, Rome, Italy; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, United Kingdom; Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA; and Neurobiologie Intégrative des Systèmes Cholinergiques, and Centre National de la Recherche Scientifique Unités Mixtes de Recherche, Institut Pasteur, Paris, France.
Claudia
C
Moriconi
*Istituto Di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli, Italy; Department of Biology and Biotechnology "Charles Darwin," and Department of Physiology and Pharmacology, Institute Pasteur-Cenci Bolognetti Foundation, Sapienza University, Rome, Italy; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, United Kingdom; Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA; and Neurobiologie Intégrative des Systèmes Cholinergiques, and Centre National de la Recherche Scientifique Unités Mixtes de Recherche, Institut Pasteur, Paris, France.
Katiuscia
K
Martinello
*Istituto Di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli, Italy; Department of Biology and Biotechnology "Charles Darwin," and Department of Physiology and Pharmacology, Institute Pasteur-Cenci Bolognetti Foundation, Sapienza University, Rome, Italy; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, United Kingdom; Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA; and Neurobiologie Intégrative des Systèmes Cholinergiques, and Centre National de la Recherche Scientifique Unités Mixtes de Recherche, Institut Pasteur, Paris, France.
Myriam
M
Catalano
*Istituto Di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli, Italy; Department of Biology and Biotechnology "Charles Darwin," and Department of Physiology and Pharmacology, Institute Pasteur-Cenci Bolognetti Foundation, Sapienza University, Rome, Italy; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, United Kingdom; Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA; and Neurobiologie Intégrative des Systèmes Cholinergiques, and Centre National de la Recherche Scientifique Unités Mixtes de Recherche, Institut Pasteur, Paris, France.
Isabel
I
Bermudez
*Istituto Di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli, Italy; Department of Biology and Biotechnology "Charles Darwin," and Department of Physiology and Pharmacology, Institute Pasteur-Cenci Bolognetti Foundation, Sapienza University, Rome, Italy; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, United Kingdom; Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA; and Neurobiologie Intégrative des Systèmes Cholinergiques, and Centre National de la Recherche Scientifique Unités Mixtes de Recherche, Institut Pasteur, Paris, France.
Jerry A
JA
Stitzel
*Istituto Di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli, Italy; Department of Biology and Biotechnology "Charles Darwin," and Department of Physiology and Pharmacology, Institute Pasteur-Cenci Bolognetti Foundation, Sapienza University, Rome, Italy; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, United Kingdom; Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA; and Neurobiologie Intégrative des Systèmes Cholinergiques, and Centre National de la Recherche Scientifique Unités Mixtes de Recherche, Institut Pasteur, Paris, France.
Uwe
U
Maskos
*Istituto Di Ricovero e Cura a Carattere Scientifico Neuromed, Pozzilli, Italy; Department of Biology and Biotechnology "Charles Darwin," and Department of Physiology and Pharmacology, Institute Pasteur-Cenci Bolognetti Foundation, Sapienza University, Rome, Italy; Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, United Kingdom; Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado, USA; and Neurobiologie Intégrative des Systèmes Cholinergiques, and Centre National de la Recherche Scientifique Unités Mixtes de Recherche, Institut Pasteur, Paris, France sergio.fucile@uniroma1.it.
Sergio
S
Fucile
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D006801:Humans; D008297:Male; D008636:Mesencephalon / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D009474:Neurons / Q000378:metabolism*; D009538:Nicotine / Q000378:metabolism; D021122:Protein Subunits / Q000378:metabolism*; D011978:Receptors, Nicotinic / Q000378:metabolism*
D021122:Protein Subunits; D011978:Receptors, Nicotinic; D009538:Nicotine; D002118:Calcium
Ca2+ permeability; fractional Ca2+ current; nicotine dependence; nicotinic acetylcholine receptors